| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | double-stranded RNA binding | 2.67e-05 | 78 | 150 | 6 | GO:0003725 | |
| GeneOntologyMolecularFunction | calcium ion binding | DLL4 PCDHGB2 ASPN PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 HMCN2 HMCN1 PLCB2 PCDHB1 | 1.67e-04 | 749 | 150 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 3.33e-04 | 4 | 150 | 2 | GO:0017067 | |
| GeneOntologyMolecularFunction | HLA-E specific inhibitory MHC class Ib receptor activity | 3.33e-04 | 4 | 150 | 2 | GO:0062082 | |
| GeneOntologyMolecularFunction | inhibitory MHC class Ib receptor activity | 3.33e-04 | 4 | 150 | 2 | GO:0062080 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 3.33e-04 | 4 | 150 | 2 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 5.52e-04 | 5 | 150 | 2 | GO:0047894 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 HMCN2 HMCN1 PCDHB1 | 1.05e-09 | 187 | 149 | 13 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 WNK1 FAT2 HMCN2 HMCN1 PCDHB1 | 6.64e-08 | 313 | 149 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | NPHS1 CRISP2 PCDHGB2 RC3H1 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 WNK1 ITGB3 MALT1 FAT2 NRXN3 HMCN2 HMCN1 CD33 PCDHB1 TNXB | 9.93e-06 | 1077 | 149 | 22 | GO:0098609 |
| Domain | Cadherin_tail | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 | 1.06e-11 | 37 | 149 | 9 | PF15974 |
| Domain | Cadherin_CBD | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 | 1.06e-11 | 37 | 149 | 9 | IPR031904 |
| Domain | Cadherin_2 | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 PCDHB1 | 9.47e-11 | 65 | 149 | 10 | PF08266 |
| Domain | Cadherin_N | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 PCDHB1 | 9.47e-11 | 65 | 149 | 10 | IPR013164 |
| Domain | Cadherin_CS | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 1.13e-09 | 109 | 149 | 11 | IPR020894 |
| Domain | CADHERIN_1 | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 1.66e-09 | 113 | 149 | 11 | PS00232 |
| Domain | Cadherin | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 1.66e-09 | 113 | 149 | 11 | PF00028 |
| Domain | CADHERIN_2 | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 1.83e-09 | 114 | 149 | 11 | PS50268 |
| Domain | - | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 1.83e-09 | 114 | 149 | 11 | 2.60.40.60 |
| Domain | CA | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 2.01e-09 | 115 | 149 | 11 | SM00112 |
| Domain | Cadherin-like | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 2.20e-09 | 116 | 149 | 11 | IPR015919 |
| Domain | Cadherin | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 2.65e-09 | 118 | 149 | 11 | IPR002126 |
| Domain | Cadherin_C | 2.03e-05 | 42 | 149 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 2.03e-05 | 42 | 149 | 5 | PF16492 | |
| Domain | Ig-like_fold | MYBPH NPHS1 TIMD4 OBSCN UNC5A MALT1 FAM187B HMCN2 HMCN1 CSF3R CD33 ERMAP TNXB IL5RA PLXNA1 MYBPC2 | 1.67e-04 | 706 | 149 | 16 | IPR013783 |
| Domain | uDENN | 1.70e-04 | 14 | 149 | 3 | SM00800 | |
| Domain | Ig-like_dom | MYBPH NPHS1 TIMD4 OBSCN UNC5A MALT1 FAM187B HMCN2 HMCN1 CSF3R CD33 ERMAP MYBPC2 | 2.01e-04 | 503 | 149 | 13 | IPR007110 |
| Domain | uDENN | 2.11e-04 | 15 | 149 | 3 | PF03456 | |
| Domain | DENN | 2.58e-04 | 16 | 149 | 3 | SM00799 | |
| Domain | DENN | 2.58e-04 | 16 | 149 | 3 | PF02141 | |
| Domain | dDENN | 2.58e-04 | 16 | 149 | 3 | PF03455 | |
| Domain | UDENN | 2.58e-04 | 16 | 149 | 3 | PS50946 | |
| Domain | DDENN | 2.58e-04 | 16 | 149 | 3 | PS50947 | |
| Domain | dDENN | 2.58e-04 | 16 | 149 | 3 | SM00801 | |
| Domain | dDENN_dom | 2.58e-04 | 16 | 149 | 3 | IPR005112 | |
| Domain | uDENN_dom | 2.58e-04 | 16 | 149 | 3 | IPR005113 | |
| Domain | DENN | 2.58e-04 | 16 | 149 | 3 | PS50211 | |
| Domain | DENN_dom | 2.58e-04 | 16 | 149 | 3 | IPR001194 | |
| Domain | - | MYBPH NPHS1 TIMD4 OBSCN UNC5A MALT1 FAM187B HMCN1 CSF3R CD33 ERMAP TNXB IL5RA PLXNA1 MYBPC2 | 2.75e-04 | 663 | 149 | 15 | 2.60.40.10 |
| Domain | G2F | 3.75e-04 | 4 | 149 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 3.75e-04 | 4 | 149 | 2 | PS50993 | |
| Domain | GFP | 3.75e-04 | 4 | 149 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 3.75e-04 | 4 | 149 | 2 | IPR006605 | |
| Domain | EGF | 5.23e-04 | 126 | 149 | 6 | PF00008 | |
| Domain | IG | MYBPH NPHS1 TIMD4 OBSCN UNC5A MALT1 HMCN2 HMCN1 CD33 ERMAP MYBPC2 | 5.72e-04 | 421 | 149 | 11 | SM00409 |
| Domain | Ig_sub | MYBPH NPHS1 TIMD4 OBSCN UNC5A MALT1 HMCN2 HMCN1 CD33 ERMAP MYBPC2 | 5.72e-04 | 421 | 149 | 11 | IPR003599 |
| Domain | Ig_I-set | 8.40e-04 | 190 | 149 | 7 | IPR013098 | |
| Domain | I-set | 8.40e-04 | 190 | 149 | 7 | PF07679 | |
| Domain | FN3 | 1.10e-03 | 199 | 149 | 7 | PS50853 | |
| Domain | LRR | 1.17e-03 | 201 | 149 | 7 | PS51450 | |
| Domain | FN3_dom | 1.46e-03 | 209 | 149 | 7 | IPR003961 | |
| Domain | LRR_1 | 1.90e-03 | 219 | 149 | 7 | PF00560 | |
| Domain | fn3 | 1.92e-03 | 162 | 149 | 6 | PF00041 | |
| Domain | IG_LIKE | MYBPH NPHS1 TIMD4 OBSCN UNC5A MALT1 HMCN2 HMCN1 CD33 ERMAP MYBPC2 | 1.97e-03 | 491 | 149 | 11 | PS50835 |
| Domain | IQ | 2.50e-03 | 71 | 149 | 4 | PF00612 | |
| Domain | IGc2 | 2.83e-03 | 235 | 149 | 7 | SM00408 | |
| Domain | Ig_sub2 | 2.83e-03 | 235 | 149 | 7 | IPR003598 | |
| Domain | Death_domain | 3.42e-03 | 38 | 149 | 3 | IPR000488 | |
| Domain | DEATH_DOMAIN | 3.42e-03 | 38 | 149 | 3 | PS50017 | |
| Domain | FN3 | 3.72e-03 | 185 | 149 | 6 | SM00060 | |
| Domain | IQ | 4.02e-03 | 81 | 149 | 4 | SM00015 | |
| Domain | - | 4.29e-03 | 321 | 149 | 8 | 3.80.10.10 | |
| Domain | EGF_1 | 4.43e-03 | 255 | 149 | 7 | PS00022 | |
| Domain | L_dom-like | 4.88e-03 | 328 | 149 | 8 | IPR032675 | |
| Domain | EGF-like_CS | 5.02e-03 | 261 | 149 | 7 | IPR013032 | |
| Domain | Ig_V-set | 5.29e-03 | 199 | 149 | 6 | IPR013106 | |
| Domain | EGF_2 | 5.44e-03 | 265 | 149 | 7 | PS01186 | |
| Domain | IQ_motif_EF-hand-BS | 5.85e-03 | 90 | 149 | 4 | IPR000048 | |
| Domain | Leu-rich_rpt | 6.13e-03 | 271 | 149 | 7 | IPR001611 | |
| Domain | IQ | 6.56e-03 | 93 | 149 | 4 | PS50096 | |
| Domain | - | 7.09e-03 | 150 | 149 | 5 | 2.30.42.10 | |
| Domain | PDZ | 7.29e-03 | 151 | 149 | 5 | PS50106 | |
| Domain | PDZ | 7.49e-03 | 152 | 149 | 5 | IPR001478 | |
| Pubmed | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 | 6.38e-16 | 24 | 154 | 9 | 24698270 | |
| Pubmed | 7.71e-16 | 15 | 154 | 8 | 15640798 | ||
| Pubmed | 2.89e-15 | 17 | 154 | 8 | 29911975 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 5.18e-15 | 18 | 154 | 8 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 5.18e-15 | 18 | 154 | 8 | 10662547 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 2.14e-14 | 72 | 154 | 11 | 10380929 |
| Pubmed | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 4.64e-14 | 77 | 154 | 11 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 FAT2 PCDHB1 | 7.20e-14 | 80 | 154 | 11 | 10716726 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 PCDHB1 | 7.79e-14 | 57 | 154 | 10 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 PCDHB1 | 9.37e-14 | 58 | 154 | 10 | 30377227 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 PCDHB1 | 5.03e-13 | 68 | 154 | 10 | 11230163 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 PCDHB1 | 1.21e-12 | 74 | 154 | 10 | 10817752 |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 3.19e-11 | 28 | 154 | 7 | 15347688 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | COL9A1 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 SULT1A3 | 1.52e-10 | 119 | 154 | 10 | 28625976 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 7.21e-10 | 11 | 154 | 5 | 9655502 | |
| Pubmed | DLL4 TAF1C PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 | 1.68e-08 | 193 | 154 | 10 | 22589738 | |
| Pubmed | 4.58e-08 | 9 | 154 | 4 | 12154121 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 FLII HIVEP2 MTHFD1L UBR4 OBSCN SFI1 SRCAP WNK1 DCTN1 DENND1A SLC1A5 MADD ARHGEF10L C6orf132 ZNF341 PI4KA SBF2 MBD5 PLXNA1 | 1.05e-07 | 1105 | 154 | 20 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 RALGAPA1 HIVEP2 MAP1B MAGI3 RAB11FIP1 WNK1 DENND1A SLC1A5 GLCCI1 MADD C6orf132 PI4KA MEPCE SKA3 PATJ MAP2K7 | 3.08e-07 | 861 | 154 | 17 | 36931259 |
| Pubmed | TANC2 RC3H1 MAGI3 UBN2 WNK1 GALNT16 EFTUD2 FAT2 PTCD1 SBF2 FHDC1 MBD5 MGA | 3.40e-07 | 493 | 154 | 13 | 15368895 | |
| Pubmed | 3.53e-07 | 101 | 154 | 7 | 10997877 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 20332152 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 9683661 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 34888534 | ||
| Pubmed | Development and function of CD94-deficient natural killer cells. | 8.46e-07 | 5 | 154 | 3 | 21151939 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 1.07e-06 | 75 | 154 | 6 | 15372022 | |
| Pubmed | TANC2 FLII DLGAP2 SEPTIN5 UBR4 UBN2 DCTN1 STRIP1 EFTUD2 AGO3 PI4KA PPP1R3F TAF5 MGA ATP2B4 TP53BP1 AGAP2 | 1.43e-06 | 963 | 154 | 17 | 28671696 | |
| Pubmed | Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. | 1.69e-06 | 6 | 154 | 3 | 11751968 | |
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 18448674 | ||
| Pubmed | Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes. | 2.94e-06 | 7 | 154 | 3 | 9598306 | |
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 4.64e-06 | 55 | 154 | 5 | 23178491 | |
| Pubmed | Viral infection modulates Qa-1b in infected and bystander cells to properly direct NK cell killing. | 4.69e-06 | 8 | 154 | 3 | 33765134 | |
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 10601355 | ||
| Pubmed | Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I. | 7.01e-06 | 9 | 154 | 3 | 14707119 | |
| Pubmed | FLII CNKSR1 TACC2 RAB11FIP1 WNK1 GLCCI1 SIRT1 STRIP1 ZNF8 TP53BP1 FTSJ3 | 1.63e-05 | 503 | 154 | 11 | 16964243 | |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 1.82e-05 | 12 | 154 | 3 | 10612399 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 12175968 | ||
| Pubmed | Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis. | 1.95e-05 | 2 | 154 | 2 | 38519981 | |
| Pubmed | Mutant analysis reveals whirlin as a dynamic organizer in the growing hair cell stereocilium. | 1.95e-05 | 2 | 154 | 2 | 15590699 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 37988467 | ||
| Pubmed | Whirler mutant hair cells have less severe pathology than shaker 2 or double mutants. | 1.95e-05 | 2 | 154 | 2 | 17619105 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 29705271 | ||
| Pubmed | PCDHA9 as a candidate gene for amyotrophic lateral sclerosis. | 1.95e-05 | 2 | 154 | 2 | 38467605 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24687878 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23226105 | ||
| Pubmed | Characterization of large-scale genomic differences in the first complete human genome. | 1.95e-05 | 2 | 154 | 2 | 37403156 | |
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 1.95e-05 | 2 | 154 | 2 | 32035013 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 12757936 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 10543947 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15752422 | ||
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 1.95e-05 | 2 | 154 | 2 | 8117269 | |
| Pubmed | Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. | 1.95e-05 | 2 | 154 | 2 | 21499261 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 14520239 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 31145702 | ||
| Pubmed | OBSCN APOB TACC2 SRCAP UBN2 WNK1 DCTN1 MADD PTCD1 ZNF341 ALDH1L2 PI4KA SBF2 PATJ MGA TP53BP1 | 2.72e-05 | 1084 | 154 | 16 | 11544199 | |
| Pubmed | FLII MAP1B ZNF174 CDK11A SRCAP SGO1 UBN2 WNK1 LIN9 ZNF8 PI4KA SKA3 | 3.27e-05 | 645 | 154 | 12 | 25281560 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLII MAP1B MTHFD1L TAF1C UBR4 SRCAP MIDEAS DCTN1 SLC1A5 DHX9 EFTUD2 SMG8 POLR1E PI4KA DDX60L MGA TP53BP1 FTSJ3 | 3.30e-05 | 1353 | 154 | 18 | 29467282 |
| Pubmed | TANC2 TAF1C EMILIN3 RAB11FIP1 SRCAP SIRT1 ZNF8 MALT1 HMCN2 AGO3 POLR1E MEPCE TAF5 MGA MAP2K7 FTSJ3 | 3.85e-05 | 1116 | 154 | 16 | 31753913 | |
| Pubmed | 5.53e-05 | 17 | 154 | 3 | 24850809 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 12388743 | ||
| Pubmed | Nurr1 represses tyrosine hydroxylase expression via SIRT1 in human neural stem cells. | 5.83e-05 | 3 | 154 | 2 | 23977047 | |
| Pubmed | TIM4-TIM1 interaction modulates Th2 pattern inflammation through enhancing SIRT1 expression. | 5.83e-05 | 3 | 154 | 2 | 28949386 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 19321927 | ||
| Pubmed | Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction. | 5.83e-05 | 3 | 154 | 2 | 23954273 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 36674478 | ||
| Pubmed | Cloning of murine NKG2A, B and C: second family of C-type lectin receptors on murine NK cells. | 5.83e-05 | 3 | 154 | 2 | 10092077 | |
| Pubmed | Tissue-protective effects of NKG2A in immune-mediated clearance of virus infection. | 5.83e-05 | 3 | 154 | 2 | 25251060 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 15650876 | ||
| Pubmed | Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease. | 5.83e-05 | 3 | 154 | 2 | 29477871 | |
| Pubmed | KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair. | 5.83e-05 | 3 | 154 | 2 | 25905708 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 12050356 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 10369936 | ||
| Pubmed | Screening for the Biomarkers Associated with Myocardial Infarction by Bioinformatics Analysis. | 5.83e-05 | 3 | 154 | 2 | 31502863 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 25878102 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 29569026 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 23340823 | ||
| Pubmed | A secreted protein promotes cleavage furrow maturation during cytokinesis. | 5.83e-05 | 3 | 154 | 2 | 21215633 | |
| Pubmed | Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells. | 5.83e-05 | 3 | 154 | 2 | 30860984 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 15654330 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 5.83e-05 | 3 | 154 | 2 | 8363592 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 9855620 | ||
| Pubmed | Identification of the hASCT2-binding domain of the Env ERVWE1/syncytin-1 fusogenic glycoprotein. | 5.83e-05 | 3 | 154 | 2 | 16820059 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 16301217 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 7961757 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 17015624 | ||
| Pubmed | Phase separation-mediated condensation of Whirlin-Myo15-Eps8 stereocilia tip complex. | 5.83e-05 | 3 | 154 | 2 | 33626355 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 12154082 | ||
| Pubmed | Synergized regulation of NK cell education by NKG2A and specific Ly49 family members. | 5.83e-05 | 3 | 154 | 2 | 31676749 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 37675109 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TANC2 WHRN CDK11A RAB11FIP1 USH1C WNK1 DCTN1 DENND1A GLCCI1 DHX9 EFTUD2 IVL LPCAT3 SPAG16 DNAAF1 CEP97 TP53BP1 | 8.29e-05 | 1321 | 154 | 17 | 27173435 |
| Pubmed | 9.16e-05 | 163 | 154 | 6 | 16512683 | ||
| Pubmed | 9.18e-05 | 20 | 154 | 3 | 37072933 | ||
| Pubmed | RALGAPA1 NDUFAF2 MTHFD1L UBR4 RAB11FIP1 DCTN1 SLC1A5 SIRT1 DHX9 HSPA13 EFTUD2 MRPL4 PTCD1 PI4KA FADS2 ATP2B4 TP53BP1 FTSJ3 | 1.10e-04 | 1487 | 154 | 18 | 33957083 | |
| Pubmed | Whirlin complexes with p55 at the stereocilia tip during hair cell development. | 1.16e-04 | 4 | 154 | 2 | 16829577 | |
| Pubmed | HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model. | 1.16e-04 | 4 | 154 | 2 | 23390293 | |
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 24318996 | ||
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 15590698 | ||
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 30275467 | ||
| Pubmed | DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells. | 1.16e-04 | 4 | 154 | 2 | 21957149 | |
| Pubmed | The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B. | 1.16e-04 | 4 | 154 | 2 | 16237464 | |
| Interaction | PCDHA10 interactions | 1.96e-10 | 22 | 153 | 7 | int:PCDHA10 | |
| Interaction | FLT3 interactions | COL9A1 MTHFD1L INPP5D UBR4 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 APOB SULT1A3 PI4KA | 2.11e-08 | 318 | 153 | 15 | int:FLT3 |
| Interaction | PCDHA7 interactions | 4.47e-08 | 14 | 153 | 5 | int:PCDHA7 | |
| Interaction | PCDHA8 interactions | 3.70e-06 | 55 | 153 | 6 | int:PCDHA8 | |
| Interaction | PCDHA9 interactions | 4.03e-06 | 32 | 153 | 5 | int:PCDHA9 | |
| Interaction | PCDHGA10 interactions | 1.13e-05 | 19 | 153 | 4 | int:PCDHGA10 | |
| Interaction | PCDHA11 interactions | 1.13e-05 | 19 | 153 | 4 | int:PCDHA11 | |
| Cytoband | 5q31 | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 PCDHB1 | 7.40e-12 | 115 | 154 | 10 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 PCDHB1 | 7.69e-08 | 298 | 154 | 10 | chr5q31 |
| Cytoband | 9q34.11 | 7.67e-04 | 53 | 154 | 3 | 9q34.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 1.18e-03 | 136 | 154 | 4 | chr16q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 1.28e-03 | 353 | 154 | 6 | chr12p13 | |
| Cytoband | 12p13 | 1.33e-03 | 64 | 154 | 3 | 12p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 1.57e-03 | 147 | 154 | 4 | chr15q15 | |
| GeneFamily | Clustered protocadherins | PCDHGB2 PCDHAC2 PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 PCDHB1 | 4.81e-12 | 64 | 109 | 10 | 20 |
| GeneFamily | CD molecules|C-type lectin domain family|Killer cell lectin like receptors | 4.51e-05 | 12 | 109 | 3 | 621 | |
| GeneFamily | Fibronectin type III domain containing | 4.18e-04 | 160 | 109 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.32e-04 | 161 | 109 | 6 | 593 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.45e-04 | 25 | 109 | 3 | 504 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 9.85e-04 | 8 | 109 | 2 | 658 | |
| GeneFamily | Fibulins | 9.85e-04 | 8 | 109 | 2 | 556 | |
| GeneFamily | PDZ domain containing | 2.28e-03 | 152 | 109 | 5 | 1220 | |
| GeneFamily | Sulfotransferases, cytosolic | 3.13e-03 | 14 | 109 | 2 | 762 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 SPAG16 PCDHB1 | 1.10e-05 | 238 | 152 | 9 | M2020 |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 1.25e-05 | 25 | 152 | 4 | M47986 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 SPAG16 PCDHB1 | 2.28e-05 | 261 | 152 | 9 | MM1277 |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 3.08e-05 | 152 | 152 | 7 | M39239 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.94e-08 | 149 | 153 | 8 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.67e-08 | 61 | 153 | 6 | 5e855b5462f42b7a1d0bbd518cc11072342ce0cc | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.67e-08 | 61 | 153 | 6 | 2fc13475581431f82e0b5ef42e18cd29c9787666 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-07 | 177 | 153 | 8 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 3.90e-07 | 195 | 153 | 8 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-06 | 157 | 153 | 7 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 168 | 153 | 7 | 17fb9426eeea407b26fb895b8397faca95b7552d | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 168 | 153 | 7 | a61b39884851384cffd430079040546d125b2b40 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 175 | 153 | 7 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-06 | 180 | 153 | 7 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-06 | 180 | 153 | 7 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.25e-06 | 182 | 153 | 7 | f7b28744d9c330b6004763aa8aa8605ba41fd1fa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.89e-06 | 187 | 153 | 7 | 6c43669e19b5b54d72d1f5d876184fee53c05f0b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.79e-06 | 193 | 153 | 7 | 1f50823bd7ef00500d9d81f0f5c2f6c940c4b1a6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.79e-06 | 193 | 153 | 7 | b9c00df1b216eaa4283315713f1c9ef552d3d435 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 5.12e-06 | 195 | 153 | 7 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 5.12e-06 | 195 | 153 | 7 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.48e-06 | 197 | 153 | 7 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.91e-06 | 77 | 153 | 5 | 9743d4a79c8694f76ab780b9e52b4c6ac1af33ed | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.91e-06 | 77 | 153 | 5 | a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.91e-06 | 77 | 153 | 5 | 22e8c486ad82773b1facd8dd55ed3f448612c600 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.91e-06 | 77 | 153 | 5 | 7e30a46aa68a9374c4c99385a383e0865ff45b1c | |
| ToppCell | ASK454-Epithelial-Type_2|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.65e-06 | 136 | 153 | 6 | ff9a5e111993fdb3ac64c5ef269e3460ff994517 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 7.65e-06 | 136 | 153 | 6 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.74e-05 | 93 | 153 | 5 | 38a075f06001a2fd1ec77fc301a08a87618a2440 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.74e-05 | 93 | 153 | 5 | a0117b12889d9c48294a7ccea4284d00c087889f | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.74e-05 | 93 | 153 | 5 | b3e057132633b25bd4f8ff2c0aa203ade0f3ba4c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.07e-05 | 162 | 153 | 6 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 166 | 153 | 6 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 166 | 153 | 6 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-05 | 166 | 153 | 6 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 166 | 153 | 6 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 169 | 153 | 6 | 573f85075d83a4baba41c3e24dc4d9831823a5e5 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 169 | 153 | 6 | a24d12199b1a6d9cb243b3a68f4109d3a30b2dcb | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-05 | 169 | 153 | 6 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.72e-05 | 102 | 153 | 5 | 2c3622fc3cd62d9b7e185d0204cf7f03e7dde73c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-05 | 171 | 153 | 6 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-05 | 171 | 153 | 6 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-05 | 172 | 153 | 6 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-05 | 174 | 153 | 6 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 175 | 153 | 6 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 176 | 153 | 6 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.51e-05 | 178 | 153 | 6 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-05 | 179 | 153 | 6 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 179 | 153 | 6 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | CV-Healthy-2|CV / Virus stimulation, Condition and Cluster | 3.74e-05 | 180 | 153 | 6 | e182e5c495dd82d4fcbf1a920086c70b064801f3 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 180 | 153 | 6 | cea62fc006d68c3815c88bf17ec2617d7e41c3d2 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-05 | 182 | 153 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-05 | 182 | 153 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 183 | 153 | 6 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 184 | 153 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 4.23e-05 | 184 | 153 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 184 | 153 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 184 | 153 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.23e-05 | 184 | 153 | 6 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.23e-05 | 184 | 153 | 6 | 8ed22b1af04a711203293e7a8b3df6fb9222fad5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 187 | 153 | 6 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 187 | 153 | 6 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 187 | 153 | 6 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.05e-05 | 190 | 153 | 6 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 5.20e-05 | 191 | 153 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.36e-05 | 192 | 153 | 6 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.36e-05 | 192 | 153 | 6 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-05 | 193 | 153 | 6 | 32eb026d4317c1499d51294d396dfd5f293f9deb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-05 | 193 | 153 | 6 | ba484fa1f290a92ae02475a4c468b4ac840c133e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-05 | 193 | 153 | 6 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.67e-05 | 194 | 153 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.67e-05 | 194 | 153 | 6 | 0fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 5.84e-05 | 195 | 153 | 6 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.84e-05 | 195 | 153 | 6 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.01e-05 | 196 | 153 | 6 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 6.01e-05 | 196 | 153 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | P03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.18e-05 | 197 | 153 | 6 | 079db904a08743b3c555cb7b3f5fb5c978dde25a | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.53e-05 | 199 | 153 | 6 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 | |
| ToppCell | control-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.53e-05 | 199 | 153 | 6 | 50e2da35edff1aadef939cfbd4549f73c1a07717 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.53e-05 | 199 | 153 | 6 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.53e-05 | 199 | 153 | 6 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-RBC|COVID-19_Severe / Disease, condition lineage and cell class | 6.71e-05 | 200 | 153 | 6 | 308f74e7e13ecc6d133c219c42cc8895a96644c8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.71e-05 | 200 | 153 | 6 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.35e-05 | 129 | 153 | 5 | b0c3cbab552e1d540e6b03a691dd245f81715e0b | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e-Excitatory_Neuron.Sc17a7.Sema3e-Onecut2_(Layer_6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.84e-05 | 68 | 153 | 4 | 5af7170acc5e4503375d84472d538e7f5dc92e1d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.90e-05 | 70 | 153 | 4 | e1ac00f4a519b6ada89f591e549874bd3eed0ca1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.90e-05 | 70 | 153 | 4 | 27e12c0f43a996bcbed285c5ee668bef5a786d80 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.90e-05 | 70 | 153 | 4 | b6815131e87e81c10e65bc398a84dab5a74b32ac | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.03e-04 | 135 | 153 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 73 | 153 | 4 | 51bcbb57ee6c45cad88cb3e2cedab2cf3503b2a5 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.23e-04 | 140 | 153 | 5 | b9aeb7dda7f377b580dd8a44912f300721437387 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 142 | 153 | 5 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 142 | 153 | 5 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.49e-04 | 146 | 153 | 5 | 7748277cf2f12e2930d4f5a22247ab9bc266a954 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 79 | 153 | 4 | cc17a013a4a57a99c404b10449ef61ce559631d1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 79 | 153 | 4 | 19fb2bc964589ea40e7b9f0809c641331c93dacd | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.75e-04 | 151 | 153 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 157 | 153 | 5 | 0362c04b7b0b5017964b3a73ee678ae53e7238d7 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 159 | 153 | 5 | 656aa20706bdba81bbcc3e68e6058215b92b8802 | |
| ToppCell | Substantia_nigra-Hematopoietic|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.29e-04 | 160 | 153 | 5 | 19d71d02f06f34eff37d268a78e5eed34da4ca44 | |
| Disease | 1,5 anhydroglucitol measurement | 9.39e-11 | 29 | 147 | 7 | EFO_0008009 | |
| Disease | visceral adipose tissue measurement, body mass index | 1.31e-08 | 87 | 147 | 8 | EFO_0004340, EFO_0004765 | |
| Disease | neutrophil count | HIVEP2 TIMD4 INPP5D RC3H1 PCDHA12 MAGI3 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 GALNT16 GLCCI1 LIN9 SIRT1 CHRNB2 IVL MRPL4 IFIH1 CSF3R CD33 SBF2 FADS2 PLCB2 TNXB | 2.16e-08 | 1382 | 147 | 25 | EFO_0004833 |
| Disease | neutrophil count, basophil count | PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 LIN9 CSF3R FADS2 | 1.98e-06 | 224 | 147 | 9 | EFO_0004833, EFO_0005090 |
| Disease | cholesterol in large HDL measurement | 5.10e-05 | 80 | 147 | 5 | EFO_0021900 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 6.27e-05 | 43 | 147 | 4 | DOID:9074 (implicated_via_orthology) | |
| Disease | immunoglobulin isotype switching measurement | 6.87e-05 | 44 | 147 | 4 | EFO_0010128 | |
| Disease | phospholipids in very small VLDL measurement | 1.23e-04 | 51 | 147 | 4 | EFO_0022300 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.46e-04 | 303 | 147 | 8 | EFO_0004612, EFO_0020945 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.66e-04 | 55 | 147 | 4 | EFO_0022234 | |
| Disease | triglycerides in large VLDL measurement | 1.78e-04 | 56 | 147 | 4 | EFO_0022178 | |
| Disease | triglycerides in very large VLDL measurement | 1.78e-04 | 56 | 147 | 4 | EFO_0022325 | |
| Disease | triglycerides in VLDL measurement | 2.18e-04 | 59 | 147 | 4 | EFO_0022326 | |
| Disease | triglycerides to total lipids in large HDL percentage | 2.32e-04 | 60 | 147 | 4 | EFO_0022330 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 2.32e-04 | 60 | 147 | 4 | EFO_0021898 | |
| Disease | triglycerides in small VLDL measurement | 2.47e-04 | 61 | 147 | 4 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 2.47e-04 | 61 | 147 | 4 | EFO_0022274 | |
| Disease | phospholipids in large VLDL measurement | 2.64e-04 | 62 | 147 | 4 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 2.64e-04 | 62 | 147 | 4 | EFO_0022322 | |
| Disease | total lipids in very large VLDL measurement | 2.64e-04 | 62 | 147 | 4 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 2.64e-04 | 62 | 147 | 4 | EFO_0022299 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 2.80e-04 | 63 | 147 | 4 | EFO_0022292 | |
| Disease | monocyte percentage of leukocytes | WNK1 GLCCI1 LIN9 MADD MRPL4 IFIH1 CSF3R PI4KA FADS2 PHLPP1 MBD5 KLRC2 | 3.12e-04 | 731 | 147 | 12 | EFO_0007989 |
| Disease | triglycerides in small LDL measurement | 3.16e-04 | 65 | 147 | 4 | EFO_0022323 | |
| Disease | cholesterol in very large VLDL measurement | 3.16e-04 | 65 | 147 | 4 | EFO_0022230 | |
| Disease | cholesteryl ester measurement | 3.17e-04 | 257 | 147 | 7 | EFO_0010351 | |
| Disease | total lipids in very large HDL measurement | 3.35e-04 | 66 | 147 | 4 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 3.35e-04 | 66 | 147 | 4 | EFO_0022298 | |
| Disease | total lipids in large VLDL | 3.55e-04 | 67 | 147 | 4 | EFO_0022175 | |
| Disease | triglycerides in very small VLDL measurement | 3.76e-04 | 68 | 147 | 4 | EFO_0022144 | |
| Disease | free cholesterol in large VLDL measurement | 3.76e-04 | 68 | 147 | 4 | EFO_0022265 | |
| Disease | cholesterol in very large HDL measurement | 3.98e-04 | 69 | 147 | 4 | EFO_0022229 | |
| Disease | Hereditary retinal dystrophy | 5.09e-04 | 7 | 147 | 2 | C0154860 | |
| Disease | very low density lipoprotein particle size measurement | 5.52e-04 | 133 | 147 | 5 | EFO_0008594 | |
| Disease | pulse pressure measurement | LETM2 MAP1B PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 SRCAP LRCH1 MADD MRPL4 SBF2 FADS2 MBD5 CEP97 | 5.88e-04 | 1392 | 147 | 17 | EFO_0005763 |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 6.34e-04 | 78 | 147 | 4 | EFO_0022187 | |
| Disease | free cholesterol in large HDL measurement | 6.65e-04 | 79 | 147 | 4 | EFO_0022157 | |
| Disease | post-traumatic stress disorder symptom measurement | 7.65e-04 | 82 | 147 | 4 | EFO_0008535 | |
| Disease | Hereditary hearing loss and deafness | 8.42e-04 | 146 | 147 | 5 | cv:C0236038 | |
| Disease | feeling nervous measurement | 9.55e-04 | 87 | 147 | 4 | EFO_0009597 | |
| Disease | phospholipids:total lipids ratio | 9.96e-04 | 227 | 147 | 6 | EFO_0020946 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 9.97e-04 | 312 | 147 | 7 | EFO_0004612, EFO_0010351 | |
| Disease | cholesterol in very small VLDL measurement | 1.05e-03 | 40 | 147 | 3 | EFO_0022231 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.05e-03 | 315 | 147 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | hip bone mineral density, age at menarche | 1.08e-03 | 10 | 147 | 2 | EFO_0004703, EFO_0007702 | |
| Disease | phosphatidylethanolamine ether measurement | 1.08e-03 | 10 | 147 | 2 | EFO_0010229 | |
| Disease | hemoglobin A1 measurement | 1.23e-03 | 520 | 147 | 9 | EFO_0007629 | |
| Disease | triglycerides in large LDL measurement | 1.29e-03 | 43 | 147 | 3 | EFO_0022319 | |
| Disease | concentration of large LDL particles measurement | 1.38e-03 | 44 | 147 | 3 | EFO_0022160 | |
| Disease | total lipids in very small VLDL measurement | 1.47e-03 | 45 | 147 | 3 | EFO_0022156 | |
| Disease | saturated fatty acids measurement | 1.47e-03 | 45 | 147 | 3 | EFO_0022304 | |
| Disease | metabolite measurement, body weight gain | 1.57e-03 | 12 | 147 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | phosphatidylcholine 34:4 measurement | 1.57e-03 | 12 | 147 | 2 | EFO_0010378 | |
| Disease | total lipids in small LDL | 1.67e-03 | 47 | 147 | 3 | EFO_0022168 | |
| Disease | free cholesterol in small VLDL measurement | 1.67e-03 | 47 | 147 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 1.67e-03 | 47 | 147 | 3 | EFO_0022275 | |
| Disease | free cholesterol in medium VLDL measurement | 1.67e-03 | 47 | 147 | 3 | EFO_0022269 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.85e-03 | 13 | 147 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | cholesterol in small LDL measurement | 1.89e-03 | 49 | 147 | 3 | EFO_0022227 | |
| Disease | Autistic Disorder | 2.02e-03 | 261 | 147 | 6 | C0004352 | |
| Disease | Abnormality of refraction | MTHFD1L PCDHAC1 PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 ZSWIM6 DCTN1 | 2.07e-03 | 673 | 147 | 10 | HP_0000539 |
| Disease | HbA1c measurement | TIMD4 SOX30 MADD NAA25 ZNF341 LPCAT3 SBF2 FADS2 MYO15A ATP2B4 | 2.11e-03 | 675 | 147 | 10 | EFO_0004541 |
| Disease | triglycerides to total lipids in large LDL percentage | 2.12e-03 | 51 | 147 | 3 | EFO_0022331 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.12e-03 | 51 | 147 | 3 | cv:CN043650 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.12e-03 | 51 | 147 | 3 | EFO_0022285 | |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA12 PCDHA10 PCDHA7 PCDHA5 PCDHA4 PCDHA2 DENND1A SPAG16 MYBPC2 | 2.19e-03 | 566 | 147 | 9 | EFO_0007660, EFO_0008354 |
| Disease | phospholipids in IDL measurement | 2.24e-03 | 52 | 147 | 3 | EFO_0022164 | |
| Disease | total lipids in medium LDL | 2.24e-03 | 52 | 147 | 3 | EFO_0022180 | |
| Disease | Ciliopathies | 2.27e-03 | 110 | 147 | 4 | C4277690 | |
| Disease | total phospholipids in lipoprotein particles measurement | 2.36e-03 | 53 | 147 | 3 | EFO_0022315 | |
| Disease | triglycerides in HDL measurement | 2.36e-03 | 53 | 147 | 3 | EFO_0022317 | |
| Disease | phosphatidylcholine 36:3 measurement | 2.48e-03 | 15 | 147 | 2 | EFO_0010381 | |
| Disease | YKL40 measurement | 2.48e-03 | 15 | 147 | 2 | EFO_0004869 | |
| Disease | total lipids in medium VLDL | 2.49e-03 | 54 | 147 | 3 | EFO_0022153 | |
| Disease | triglycerides in medium HDL measurement | 2.49e-03 | 54 | 147 | 3 | EFO_0022321 | |
| Disease | myeloid white cell count | TIMD4 RC3H1 GALNT16 GLCCI1 LIN9 IFIH1 CSF3R CD33 SBF2 FADS2 PLCB2 ATP2B4 | 2.62e-03 | 937 | 147 | 12 | EFO_0007988 |
| Disease | triglycerides in medium VLDL measurement | 2.63e-03 | 55 | 147 | 3 | EFO_0022155 | |
| Disease | triglycerides in very large HDL measurement | 2.63e-03 | 55 | 147 | 3 | EFO_0022324 | |
| Disease | triglycerides in LDL measurement | 2.77e-03 | 56 | 147 | 3 | EFO_0022320 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.77e-03 | 56 | 147 | 3 | EFO_0022333 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 2.77e-03 | 56 | 147 | 3 | EFO_0022316 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.77e-03 | 56 | 147 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.77e-03 | 56 | 147 | 3 | EFO_0022251 | |
| Disease | sphingomyelin measurement | 2.77e-03 | 278 | 147 | 6 | EFO_0010118 | |
| Disease | nervousness | 2.83e-03 | 16 | 147 | 2 | NCIT_C74532 | |
| Disease | response to hydrochlorothiazide, systolic blood pressure change measurement | 2.83e-03 | 16 | 147 | 2 | EFO_0005202, EFO_0006944 | |
| Disease | sickle cell anemia (is_implicated_in) | 2.83e-03 | 16 | 147 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | DLL4 NOA1 UBR4 SH2D3A OBSCN TACC2 WNK1 GALNT16 SIRT1 NAA25 MAP2K7 TP53BP1 AGAP2 | 2.85e-03 | 1074 | 147 | 13 | C0006142 |
| Disease | peripheral arterial disease, traffic air pollution measurement | 2.93e-03 | 194 | 147 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | triglycerides in IDL measurement | 3.06e-03 | 58 | 147 | 3 | EFO_0022149 | |
| Disease | hypothyroidism | 3.08e-03 | 284 | 147 | 6 | EFO_0004705 | |
| Disease | eosinophil count | HIVEP2 INPP5D WNK1 ITGB3 GLCCI1 IFIH1 MALT1 NAA25 CD33 LPCAT3 SBF2 FADS2 MBD5 TNXB IL5RA TP53BP1 | 3.12e-03 | 1488 | 147 | 16 | EFO_0004842 |
| Disease | triglycerides to total lipids in small LDL percentage | 3.21e-03 | 59 | 147 | 3 | EFO_0022337 | |
| Disease | phospholipids in VLDL measurement | 3.21e-03 | 59 | 147 | 3 | EFO_0022301 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 3.21e-03 | 59 | 147 | 3 | EFO_0022248 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 3.21e-03 | 59 | 147 | 3 | EFO_0022260 | |
| Disease | phospholipids in small VLDL measurement | 3.37e-03 | 60 | 147 | 3 | EFO_0022146 | |
| Disease | total lipids in IDL | 3.37e-03 | 60 | 147 | 3 | EFO_0022161 | |
| Disease | total lipids in VLDL measurement | 3.37e-03 | 60 | 147 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 3.37e-03 | 60 | 147 | 3 | EFO_0022237 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HIGLIPVKSSPDEPL | 166 | Q9Y6N9 | |
| PSLQIVKSEELAPGP | 596 | Q68DN1 | |
| PELIQVKSELPLDPL | 496 | Q15758 | |
| VKSELPLDPLPVPTE | 501 | Q15758 | |
| LTSQSLIPPLIKPGL | 121 | Q9H0P7 | |
| VIVLLPVPRLEGIPK | 1086 | Q9HCE6 | |
| VPGPGLVKDSPLLLQ | 1081 | Q14203 | |
| LLNSSVPPGEPLEIK | 271 | Q3SY69 | |
| GFLLPKGTPVIPLLT | 376 | Q8TAV3 | |
| PEALPPDALISKIAI | 131 | Q9NR61 | |
| LISLTLVKLESVPPP | 16 | Q99490 | |
| ILPEPLLKSIGQRPL | 461 | Q9P1A6 | |
| CPVKLLGPLLPASDL | 461 | Q86VQ1 | |
| LSPVVRKLGVPLLPL | 156 | Q4G176 | |
| LAIPEPNGVIKSPLL | 611 | Q96K78 | |
| TGRTLPEPLELDKPI | 141 | Q9H9G7 | |
| IVVLGSPKPEEIPLT | 266 | Q6UB35 | |
| LKLQPLSPVPSDIEI | 351 | Q6UB35 | |
| TVLLPSLPAEGKDPA | 11 | P16562 | |
| KLTSVPKGLPPTLLE | 231 | Q9BXN1 | |
| PSPDVFLPKVLDLIV | 491 | P23634 | |
| TKIPSPLITEEGPNL | 116 | Q9H095 | |
| PELTVPVKEALPGII | 421 | Q8N428 | |
| PPDLLESVPKSISAL | 536 | Q5TC82 | |
| IHKGIPLEELPPLSL | 671 | Q6ZP01 | |
| PLEELPPLSLESKLL | 676 | Q6ZP01 | |
| KEPLLKIPESTPLGS | 136 | Q9Y5F3 | |
| ELPDKFIIPGSPAII | 881 | Q9Y5H9 | |
| LKLELIPDVTIPPSI | 451 | Q8IWT6 | |
| LPELKALDGIPIEPS | 1051 | Q6ZRR7 | |
| ESKELLENIPPGPLS | 406 | A5PLL1 | |
| LPDKFIIPGSPAIIS | 871 | Q9UN72 | |
| LKPLLIGELAPEEPS | 86 | O95864 | |
| PPLSPLALGIKEHEL | 661 | Q9C0D6 | |
| ILVPPKLLLLTPEAG | 131 | O60500 | |
| LIDVKPKPIEIPLSG | 391 | Q2VYF4 | |
| PAPEGSPLVLVLKDL | 231 | Q5T9C9 | |
| KLEPVPLKGTSLDPR | 631 | Q13045 | |
| DLPDEIPLPLVIGTK | 211 | Q5TKA1 | |
| EVLPILPEPESLELK | 411 | Q8WXG6 | |
| IEKVLSPLRSPPLIG | 1391 | P46821 | |
| SSQPELVTIPLIKGP | 571 | Q5TCQ9 | |
| LVEFISPKTPKPGEL | 441 | Q96IV0 | |
| PVEILIPKDITDPLS | 226 | Q7L2J0 | |
| LLLPQPEVLSPTVKG | 1186 | Q8IWI9 | |
| LLSPPGIKITVNPES | 121 | Q9UDY8 | |
| PKILRPALLPGEEIV | 871 | Q86WG5 | |
| EKLEVPLPPSLDIPL | 491 | Q9UKN7 | |
| EVLIPPSISKDDPLA | 2636 | Q8NDA2 | |
| LTHRPKILIPGTLEP | 141 | P20138 | |
| DLPILKSDDPVVPSL | 461 | Q5H9U9 | |
| VLEPLSPTGLLELKP | 1151 | Q9UIW2 | |
| RLKVPEDLPPGTVLT | 931 | Q9NYQ8 | |
| VLTKVLQEEPPLLPG | 331 | O14733 | |
| LPEDSPPGTVIALIK | 356 | Q9Y5G2 | |
| LGKPLCPPEILSETL | 51 | Q9UHL3 | |
| LKPQPDIVLLPLPTA | 1506 | Q9Y4C0 | |
| LLDPPPEVSALINKL | 871 | P42356 | |
| VDTLLALGEKAPPPT | 681 | Q9Y2L9 | |
| LIDIPGKIPNSIIPA | 216 | Q6P1A2 | |
| LTGKIPTLLGPLQTP | 291 | A6NHZ5 | |
| PDKFIIPGSPAIISI | 871 | Q9Y5H7 | |
| LVPPIIKGANSDLPE | 2866 | Q96RW7 | |
| ELPDKFIIPGSPAII | 881 | Q9Y5I2 | |
| DIPVVLTRPLEPKTG | 2466 | Q5VST9 | |
| ELPDKFIIPGSPAII | 896 | Q9H158 | |
| LPDKFIIPGSPAIIS | 941 | Q9Y5I4 | |
| LPDKFIIPGSPAIIS | 881 | Q9UN74 | |
| GPRLPEKETLLSLPA | 506 | Q5T0Z8 | |
| DSPIKVPLLLSEPIN | 2021 | P04114 | |
| DLLPDEKISLLPPVN | 21 | Q01344 | |
| RLKAELGIPLEEVPP | 111 | Q13907 | |
| ALLPAPIPPVTLEEK | 181 | Q8IVS8 | |
| LLPCPEPTIISAILK | 481 | Q8IW35 | |
| KPVIPLPQILGLTAS | 476 | Q9BYX4 | |
| PDSPALLPIELKQEL | 396 | Q9UQ88 | |
| PGLGTPPITKLTVLE | 686 | Q99062 | |
| LSPVPALKPTPELEL | 261 | Q12967 | |
| ALKPTPELELALTPA | 266 | Q12967 | |
| PEPLIIPTKAGTFIA | 606 | Q6PJG2 | |
| LTSEKDPLGILDPIP | 351 | Q9P267 | |
| GTLPAETLLLSPPVK | 466 | Q8NEP3 | |
| LLETLHKLPIPDPGV | 131 | Q8TEH3 | |
| PECPKGPDILVVLLS | 711 | P05106 | |
| IESLPIKPRGPIDID | 201 | P20849 | |
| LPLPTPKVIGIDLGT | 26 | P48723 | |
| RGPLTPPLDEILSKV | 241 | Q9NT22 | |
| PEGSLLIKDPLPSQT | 76 | Q17R55 | |
| SLKDLPTVLPPGFTI | 96 | P08397 | |
| LTGEVKSPELLFDPP | 1296 | Q6ZTR5 | |
| PPPEKLTAEVLGIIC | 66 | O43908 | |
| LPDLPALVGPKQLIV | 231 | Q8NC60 | |
| PEDPSVPVALNIGKL | 301 | Q08211 | |
| LTVGLPPEPREKIIS | 851 | P46019 | |
| PDKFIIPGSPAIISI | 876 | Q9UN75 | |
| LVPPPAIIDKLFLDT | 581 | P43354 | |
| VKDPESLLVPAPLSG | 361 | Q8ND04 | |
| EEDHKLGTLSLPLPP | 391 | Q9GZS1 | |
| ELKDIILSLPPDLGP | 451 | Q96PL5 | |
| VAVKLEPEGPPTLLP | 11 | Q15542 | |
| KQPPTASTGPELLLL | 1071 | A8K8P3 | |
| EGPPLLPKAELQTES | 626 | Q6WKZ4 | |
| KGTPPEEISAAQPLL | 516 | Q9UQF0 | |
| EGLPEPVLRKVELPV | 41 | Q9BYD3 | |
| ILPLPTPDAETEKLI | 331 | Q99719 | |
| PPPEKLTAEVLGIIC | 66 | P26717 | |
| LKAPTIGLAAVVPPL | 561 | Q15572 | |
| KDLPQIPLEETELPG | 136 | Q5FBB7 | |
| LIVGVDLVPIKPLPN | 71 | Q8IY81 | |
| KRSILGLPPLPEDSI | 311 | Q5VSL9 | |
| GLPPLPEDSIKVIRN | 316 | Q5VSL9 | |
| GETLPKLKPIISDPE | 781 | Q92835 | |
| PEPGILSPSIVLTKA | 1051 | Q92835 | |
| PGLALPLKPETAISV | 581 | Q8N196 | |
| EFLIPPSLKPEIDIP | 181 | Q5VXU9 | |
| PSLKPEIDIPSLSEL | 186 | Q5VXU9 | |
| ILKDLLPETIPPPEL | 201 | Q96EB6 | |
| PDISLKPLLFEVPSI | 321 | Q9HCD6 | |
| ILVIEKPGPPSSIRL | 261 | Q13203 | |
| PPPEKLTAEVLGIIC | 66 | Q07444 | |
| PPGLLEPTSTLVRVK | 806 | Q9P202 | |
| QPALPTKGEVLLPVE | 556 | P07476 | |
| SLSLVPPKDLLPVAV | 2576 | Q6ZRS2 | |
| SGLETLKDTPPPRLI | 91 | P0DMN0 | |
| SGLETLKDTPPPRLI | 91 | P0DMM9 | |
| KDVPLTVLPSDAGIP | 311 | O94993 | |
| LGAATIEPPKPIPLT | 936 | P63128 | |
| GLVVPLLPRDKEAPS | 36 | Q3KNW1 | |
| LLISKIVPPTSLDVP | 281 | P17787 | |
| PSPLVGLKPLQLLEI | 181 | Q13705 | |
| GLSLVLKKIPIPETP | 276 | Q969H4 | |
| PPEVTKIPEDILQLL | 361 | Q8IX90 | |
| RKVLTPLPDPLGLEE | 761 | Q9BYN7 | |
| PTLPEGLPVLLEKRI | 446 | Q6ZU65 | |
| PVPKPALISLLERGD | 56 | P17023 | |
| PLLQEPTPKLAGTEA | 196 | Q15697 | |
| SPGSLEIPKDLPDIL | 861 | Q6GYQ0 | |
| DLLISEPPIVLETKP | 181 | Q96G30 | |
| LIGIRLTLPPPKVVD | 31 | Q4U2R6 | |
| VEPLKPPALFLTGAV | 471 | Q8NI35 | |
| DPVLLKAPAPLGTVA | 181 | Q9BRG2 | |
| KLLPIVSIDIGPSPG | 551 | Q8N0X2 | |
| ASKPPLEPRLGELTV | 1571 | P22105 | |
| TPEPPIKPRLGELTV | 1981 | P22105 | |
| TAPLEKELPPHLGEL | 3441 | P22105 | |
| LLSKETSEELLPPPV | 111 | Q8N183 | |
| KPPAGKVLLDDTVPL | 6 | Q7Z7A4 | |
| DPISGKEPASPVLLQ | 686 | Q6ZSY5 | |
| ALLEETPLEPAVGPK | 2186 | O95359 | |
| FTLPKEGDIIPPLTG | 906 | Q12888 | |
| VPLPSPEDLRGKILI | 446 | Q00722 | |
| ISLLIPPDAIPRGKI | 461 | Q6ZN44 | |
| LPPGKTQSPESLLDI | 66 | Q9HCJ5 | |
| LLSIGPELPKPEVIS | 61 | P17098 | |
| ELSEVTLPENLPPKL | 1116 | O60346 | |
| LTKAPVLPVGTELPA | 1756 | Q9H4A3 | |
| IVPGDPLDKSIVIRP | 906 | Q15029 | |
| LKPPPVELEVNLLTP | 431 | O75127 | |
| PILIIPKSGIPLPNE | 326 | P31629 | |
| TPGQTEVKIDLPLPI | 3621 | Q5T4S7 | |
| GLLTPEPSKEGPILT | 211 | Q96H15 | |
| VPEGLLKDLLPGPVT | 136 | Q86U90 | |
| VVPLSTPTEDKLALP | 391 | Q14CX7 | |
| KLRLDVSITGEPPPV | 561 | Q14324 |